ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 42 filers reported holding ADC THERAPEUTICS SA in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,612,000 | -39.4% | 334,384 | 0.0% | 0.38% | -48.2% |
| Q2 2022 | $2,658,000 | -45.9% | 334,384 | 0.0% | 0.74% | -44.0% |
| Q1 2022 | $4,912,000 | -27.9% | 334,384 | -0.9% | 1.32% | +6.1% |
| Q4 2021 | $6,815,000 | -27.2% | 337,396 | -2.1% | 1.24% | -14.4% |
| Q3 2021 | $9,357,000 | +76.2% | 344,519 | +58.0% | 1.45% | +66.4% |
| Q2 2021 | $5,309,000 | -0.2% | 218,027 | 0.0% | 0.87% | +30.3% |
| Q1 2021 | $5,322,000 | -84.6% | 218,027 | -79.8% | 0.67% | -77.6% |
| Q4 2020 | $34,548,000 | +94.1% | 1,079,296 | +100.0% | 2.98% | -30.4% |
| Q3 2020 | $17,803,000 | -29.5% | 539,648 | 0.0% | 4.29% | -36.1% |
| Q2 2020 | $25,261,000 | – | 539,648 | – | 6.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
| GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
| Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
| MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
| Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
| Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
| Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
| Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
| HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
| Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |